Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 74026 - 74050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silver	Approved Investigational	MIR610	693195	downregulated	Silver results in decreased expression of MIR610 mRNA	11p14.1	A24215
Silver	Approved Investigational	MIR616	693201	upregulated	Silver analog results in increased expression of MIR616 mRNA	12q13.3	A24215
Silver	Approved Investigational	MIR622	693207	downregulated	Silver analog results in decreased expression of MIR622 mRNA	13q31.3	A24215
Silver	Approved Investigational	MIR622	693207	downregulated	Silver results in decreased expression of MIR622 mRNA	13q31.3	A24215
Silver	Approved Investigational	MIR624	693209	downregulated	Silver results in decreased expression of MIR624 mRNA	14q12	A24216
Silver	Approved Investigational	MIR628	693213	upregulated	Silver analog results in increased expression of MIR628 mRNA	15q21.3	A24215
Silver	Approved Investigational	MIR632	693217	downregulated	Silver analog results in decreased expression of MIR632 mRNA	17q11.2	A24215
Silver	Approved Investigational	MIR632	693217	downregulated	Silver results in decreased expression of MIR632 mRNA	17q11.2	A24215
Silver	Approved Investigational	MIR636	693221	downregulated	Silver results in decreased expression of MIR636 mRNA	17q25.1	A24216
Silver	Approved Investigational	MIR641	693226	downregulated	Silver results in decreased expression of MIR641 mRNA	19q13.2	A24216
Silver	Approved Investigational	MIR649	693234	downregulated	Silver results in decreased expression of MIR649 mRNA	22q11.21	A24216
Silver	Approved Investigational	MIR654	724024	downregulated	Silver analog results in decreased expression of MIR654 mRNA	14q32.31	A24215
Silver	Approved Investigational	MIR654	724024	downregulated	Silver results in decreased expression of MIR654 mRNA	14q32.31	A24215
Silver	Approved Investigational	MIR659	724029	upregulated	Silver analog results in increased expression of MIR659 mRNA	22q13.1	A24215
Silver	Approved Investigational	MIR659	724029	upregulated	Silver results in increased expression of MIR659 mRNA	22q13.1	A24215
Silver	Approved Investigational	MIR760	100126348	upregulated	Silver analog results in increased expression of MIR760 mRNA	1p22.1	A24215
Silver	Approved Investigational	MIR767	768215	downregulated	Silver analog results in decreased expression of MIR767 mRNA	Xq28	A24215
Silver	Approved Investigational	MIR767	768215	downregulated	Silver results in decreased expression of MIR767 mRNA	Xq28	A24215
Silver	Approved Investigational	MIR877	100126314	upregulated	Silver analog results in increased expression of MIR877 mRNA	6p21.33	A24215
Silver	Approved Investigational	MIR877	100126314	downregulated	Silver results in decreased expression of MIR877 mRNA	6p21.33	A24216
Silver	Approved Investigational	MIR92A2	407049	upregulated	Silver analog results in increased expression of MIR92A2 mRNA	Xq26.2	A24215
Silver	Approved Investigational	MIR92A2	407049	downregulated	Silver results in decreased expression of MIR92A2 mRNA	Xq26.2	A24216
Silver	Approved Investigational	MIR92A2	407049	upregulated	Silver results in increased expression of MIR92A2 mRNA	Xq26.2	A24215
Silver	Approved Investigational	MIR933	100126350	upregulated	Silver results in increased expression of MIR933 mRNA	2q31.1	A24216
Silver	Approved Investigational	MIR935	100126325	upregulated	Silver analog results in increased expression of MIR935 mRNA	19q13.42	A24215

Displaying entries 74026 - 74050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability